{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ACE2", "COVID-19", "TMPRSS2", "alkaloid", "spike glycoprotein"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33089728", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "02"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.1080/07391102.2020.1835726"], "Journal": {"ISSN": "1538-0254", "JournalIssue": {"Volume": "40", "Issue": "5", "PubDate": {"Year": "2022", "Month": "Mar"}}, "Title": "Journal of biomolecular structure & dynamics", "ISOAbbreviation": "J Biomol Struct Dyn"}, "ArticleTitle": "Prevention of SARS-CoV-2 cell entry: insight from <i>in silico</i> interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2.", "Pagination": {"StartPage": "2121", "EndPage": "2145", "MedlinePgn": "2121-2145"}, "Abstract": {"AbstractText": ["COVID-19 is a respiratory disease caused by SARS-CoV-2, an enveloped positive sense RNA virus. The SARS-CoV-2 spike glycoprotein, <i>human</i> angiotensin-converting enzyme 2 (ACE2) and human transmembrane protease serine 2 (TMPRSS2) are essential for the host cell-mediated viral entry. Targeting these proteins represent viable options to stop the first stage of infection and transmission. Hence, 97 alkaloids from African medicinal plants with reported antiviral activity were evaluated for this purpose via <i>in silico</i> studies. These alkaloids were docked for their interactions with SARS-CoV-2 spike glycoprotein, ACE2, and TMPRSS2. Top 20 alkaloids with highest binding affinities were further screened for their interactions with spike glycoprotein of SARS-CoV and MERS-CoV, and with ACE2-SARS-CoV-2 receptor-binding domain complex (ACE2-RBD). The energy profiling, molecular dynamics simulation (MDS), binding free energy base on Molecular Mechanics/Generalized Born Surface Area (MMGBSA), clustering of MDS trajectories, and virtual physicochemical and pharmacokinetic screening of the best docked alkaloids were performed. Results revealed that more than 15 alkaloids interacted better than the reference compounds. 10-Hydroxyusambarensine and Cryptospirolepine were docked in a similar binding pattern to the S1-specificy pocket of TMPRSS2 as camostat (reference inhibitor). The strong binding affinities, stability of the alkaloid-protein complexes and amino acid interactions displayed by cryptospirolepine, 10-hydroxyusambarensine, and cryptoquindoline with important binding hotspots of the proteins suggest these alkaloids have the potential of altering the capacity of SARS-CoV-2 membrane mediated host cell entry. Further <i>in\u00a0vitro</i> and <i>in\u00a0vivo</i> evaluation of these \"drug-like\" alkaloids as potential inhibitors of coronavirus cell entry is proposed.Communicated by Ramaswamy H. Sarma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Salem University, Lokoja, Nigeria."}], "LastName": "Gyebi", "ForeName": "Gideon A", "Initials": "GA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Life Sciences, Department of Biochemistry, University of Ilorin, Ilorin, Nigeria."}], "LastName": "Adegunloye", "ForeName": "Adegbenro P", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Sciences, Department of Biophysics, Cairo University, Giza, Egypt."}], "LastName": "Ibrahim", "ForeName": "Ibrahim M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Salem University, Lokoja, Nigeria."}], "LastName": "Ogunyemi", "ForeName": "Oludare M", "Initials": "OM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Basic Medical Sciences, Department of Pharmacology and Therapeutics, University of Ilorin, Ilorin, Nigeria."}], "LastName": "Afolabi", "ForeName": "Saheed O", "Initials": "SO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, KolaDaisi University, Ibadan, Nigeria."}], "LastName": "Ogunro", "ForeName": "Olalekan B", "Initials": "OB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Biomol Struct Dyn", "NlmUniqueID": "8404176", "ISSNLinking": "0739-1102"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycoproteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Pharmaceutical Preparations"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}, {"RegistryNumber": "EC 3.4.21.-", "NameOfSubstance": "Serine Endopeptidases"}, {"RegistryNumber": "EC 3.4.21.-", "NameOfSubstance": "TMPRSS2 protein, human"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glycoproteins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Pharmaceutical Preparations"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Serine Endopeptidases"}, {"QualifierName": [], "DescriptorName": "Virus Internalization"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "No potential conflict of interest was reported by the authors."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aanouz, I., Belhassan, A., & El-Khatabi, K. (2020). Moroccan medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. Journal of Biomolecular Structure and Dynamics, 1\u20139.", "ArticleIdList": ["PMC7212546", "32306860"]}, {"Citation": "Adeoye, A. O., Oso, B. J., & Olaoye, I. F. (2020). Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. Journal of Biomolecular Structure and Dynamics, 1\u201314.", "ArticleIdList": ["PMC7232887", "32375574"]}, {"Citation": "Al-Tawfiq, J. A., & Memish, Z. A. (2014). Middle East respiratory syndrome coronavirus: Transmission and phylogenetic evolution. Trends in Microbiology, 22(10), 573\u2013579. 10.1016/j.tim.2014.08.001", "ArticleIdList": ["10.1016/j.tim.2014.08.001", "PMC7133228", "25178651"]}, {"Citation": "Bertram, S., Heurich, A., Lavender, H., Gierer, S., Danisch, S., Perin, P., Lucas, J. M., Nelson, P. S., P\u00f6hlmann, S., & Soilleux, E. J. (2012). Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PloS One, 7(4), e35876. 10.1371/journal.pone.0035876", "ArticleIdList": ["10.1371/journal.pone.0035876", "PMC3340400", "22558251"]}, {"Citation": "Bolles, M., Donaldson, E., & Baric, R. (2011). SARS-CoV and emergent coronaviruses: Viral determinants of interspecies transmission. Current Opinion in Virology, 1(6), 624\u2013634. 10.1016/j.coviro.2011.10.012", "ArticleIdList": ["10.1016/j.coviro.2011.10.012", "PMC3237677", "22180768"]}, {"Citation": "Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 Coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1\u201314.", "ArticleIdList": ["PMC7196923", "32306836"]}, {"Citation": "Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., \u2026 Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30(10), 1545\u20131614. 10.1002/jcc.21287", "ArticleIdList": ["10.1002/jcc.21287", "PMC2810661", "19444816"]}, {"Citation": "Cabe\u00e7a, T. K., Granato, C., & Bellei, N. (2013). Epidemiological and clinical features of human coronavirus infections among different subsets of patients. Influenza and Other Respiratory Viruses, 7(6), 1040\u20131047. 10.1111/irv.12101", "ArticleIdList": ["10.1111/irv.12101", "PMC4634278", "23462106"]}, {"Citation": "Case, D., Belfon, K., & Ben-Shalom, I. (2020). AMBER 2020."}, {"Citation": "Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). AdmetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099\u20133105. 10.1021/ci300367a", "ArticleIdList": ["10.1021/ci300367a", "23092397"]}, {"Citation": "Dhama, K., Karthik, K., Khandia, R., Munjal, A., Tiwari, R., Rana, R., Khurana, S. K., Ullah, S., Khan, R. U., Alagawany, M., & Farag, M. R. (2018). Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens-current knowledge and future prospects. Current Drug Metabolism, 19(3), 236\u2013263. 10.2174/1389200219666180129145252", "ArticleIdList": ["10.2174/1389200219666180129145252", "29380697"]}, {"Citation": "Elmezayen, A. D., Al-Obaidi, A., & \u015eahin, A. T. (2020). Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1\u201312.", "ArticleIdList": ["PMC7189413", "32306862"]}, {"Citation": "Gallagher, T. M., & Buchmeier, M. J. (2001). Coronavirus spike proteins in viral entry and pathogenesis. Virology, 279(2), 371\u2013374. 10.1006/viro.2000.0757", "ArticleIdList": ["10.1006/viro.2000.0757", "PMC7133764", "11162792"]}, {"Citation": "Gaunt, E. R. R., Hardie, A., Claas, E. C. C. J., Simmonds, P., & Templeton, K. E. E. (2010). Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. Journal of Clinical Microbiology, 48(8), 2940\u20132947. 10.1128/JCM.00636-10", "ArticleIdList": ["10.1128/JCM.00636-10", "PMC2916580", "20554810"]}, {"Citation": "Glowacka, I., Bertram, S., M\u00fcller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., Niemeyer, D., Schneider, H., Drosten, C., & P\u00f6hlmann, S. (2011). Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of Virology, 85(9), 4122\u20134134. 10.1128/JVI.02232-10", "ArticleIdList": ["10.1128/JVI.02232-10", "PMC3126222", "21325420"]}, {"Citation": "Gorbalenya, A. E., Baker, S. C., & Baric, R. S. (2020). The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology\u00a05(4), 536\u2013544.", "ArticleIdList": ["PMC7095448", "32123347"]}, {"Citation": "Gyebi, A. G., Ogunro, B. O., Adegunloye, P. A., Ogunyemi, M. O., & Afolabi, O. S. (2020). Potential inhibitors of Coronavirus 3-Chymotrypsin-Like Protease (3CLpro): An in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, (in press) 10.1080/7391102.2021764868", "ArticleIdList": ["10.1080/7391102.2021764868", "PMC7256353", "32367767"]}, {"Citation": "Heurich, A., Hofmann-Winkler, H., Gierer, S., Liepold, T., Jahn, O., & P\u00f6hlmann, S. (2014). TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. Journal of Virology, 88(2), 1293\u20131307. 10.1128/JVI.02202-13", "ArticleIdList": ["10.1128/JVI.02202-13", "PMC3911672", "24227843"]}, {"Citation": "Hendaus, M. A. (2020). Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19): A simplified summary. Journal of Biomolecular Structure and Dynamics, 1\u201310.", "ArticleIdList": ["PMC7256348", "32396771"]}, {"Citation": "Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kr\u00fcger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., M\u00fcller, M. A., Drosten, C., & P\u00f6hlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271\u2013280.e8. 10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33\u201338. 10.1016/0263-7855(96)00018-5", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., Crackower, M. A., Fukamizu, A., Hui, C.-C., Hein, L., Uhlig, S., Slutsky, A. S., Jiang, C., & Penninger, J. M. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature, 436(7047), 112\u2013116. 10.1038/nature03712", "ArticleIdList": ["10.1038/nature03712", "PMC7094998", "16001071"]}, {"Citation": "Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., & Matsuyama, S. (2012). Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. Journal of Virology, 86(12), 6537\u20136545. 10.1128/JVI.00094-12", "ArticleIdList": ["10.1128/JVI.00094-12", "PMC3393535", "22496216"]}, {"Citation": "Khan, R. J., Jha, R. K., & Amera, G. (2020). Targeting SARS-Cov-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1\u201340.", "ArticleIdList": ["PMC7189412", "32266873"]}, {"Citation": "Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., Bao, L., Zhang, B., Liu, G., Wang, Z., Chappell, M., Liu, Y., Zheng, D., Leibbrandt, A., Wada, T., \u2026 Penninger, J. M. (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Medicine, 11(8), 875\u2013879. 10.1038/nm1267", "ArticleIdList": ["10.1038/nm1267", "PMC7095783", "16007097"]}, {"Citation": "Kudi, A. C., & Myint, S. H. (1999). Antiviral activity of some Nigerian medicinal plant extracts. Journal of Ethnopharmacology, 68(1\u20133), 289\u2013294. 10.1016/S0378-8741(99)00049-5", "ArticleIdList": ["10.1016/S0378-8741(99)00049-5", "10624890"]}, {"Citation": "Kyrieleis, O. J. P., Huber, R., Ong, E., Oehler, R., Hunter, M., Madison, E. L., & Jacob, U. (2007). Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family. The FEBS Journal, 274(8), 2148\u20132160. 10.1111/j.1742-4658.2007.05756.x", "ArticleIdList": ["10.1111/j.1742-4658.2007.05756.x", "17388811"]}, {"Citation": "Lee, J., Cheng, X., Swails, J. M., Yeom, M. S., Eastman, P. K., Lemkul, J. A., Wei, S., Buckner, J., Jeong, J. C., Qi, Y., Jo, S., Pande, V. S., Case, D. A., Brooks, C. L., MacKerell, A. D., Klauda, J. B., & Im, W. (2016). CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. Journal of Chemical Theory and Computation, 12(1), 405\u2013413. 10.1021/acs.jctc.5b00935", "ArticleIdList": ["10.1021/acs.jctc.5b00935", "PMC4712441", "26631602"]}, {"Citation": "Letko, M., Marzi, A., & Munster, V. (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature Microbiology, 5(4), 562\u2013568. 10.1038/s41564-020-0688-y", "ArticleIdList": ["10.1038/s41564-020-0688-y", "PMC7095430", "32094589"]}, {"Citation": "Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005). Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science (New York, N.Y.), 309(5742), 1864\u20131868. 10.1126/science.1116480", "ArticleIdList": ["10.1126/science.1116480", "16166518"]}, {"Citation": "Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 426(6965), 450\u2013454. 10.1038/nature02145", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1\u20133), 3\u201325. 10.1016/S0169-409X(96)00423-1", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Lobo-Galo, N., Terrazas-L\u00f3pez, M., & Mart\u00ednez-Mart\u00ednez, A. (2020). FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics, 1\u201312.", "ArticleIdList": ["PMC7232886", "32364011"]}, {"Citation": "Lu, R., Yu, X., Wang, W., Duan, X., Zhang, L., Zhou, W., Xu, J., Xu, L., Hu, Q., Lu, J., Ruan, L., Wang, Z., & Tan, W. (2012). Characterization of human coronavirus etiology in Chinese adults with acute upper respiratory tract infection by real-time RT-PCR assays. PloS One., 7(6), e38638. 10.1371/journal.pone.0038638", "ArticleIdList": ["10.1371/journal.pone.0038638", "PMC3376151", "22719912"]}, {"Citation": "Meyer, J. J. M., Afolayan, A. J., Taylor, M. B., & Erasmus, D. (1997). Antiviral activity of galangin isolated from the aerial parts of Helichrysum aureonitens. Journal of Ethnopharmacology, 56(2), 165\u2013169. 10.1016/S0378-8741(97)01514-6", "ArticleIdList": ["10.1016/S0378-8741(97)01514-6", "9174978"]}, {"Citation": "Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314\u20133321. 10.1021/ct300418h", "ArticleIdList": ["10.1021/ct300418h", "26605738"]}, {"Citation": "Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785\u20132791. 10.1002/jcc.21256", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Muralidharan, N., Sakthivel, R., & Velmurugan, D. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1\u20137.", "ArticleIdList": ["32248766"]}, {"Citation": "O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33 10.1186/1758-2946-3-33", "ArticleIdList": ["10.1186/1758-2946-3-33", "PMC3198950", "21982300"]}, {"Citation": "Ogbole, O. O., Akinleye, T. E., Segun, P. A., Faleye, T. C., & Adeniji, A. J. (2018). In vitro antiviral activity of twenty-seven medicinal plant extracts from Southwest Nigeria against three serotypes of echoviruses. Virology Journal, 15(1), 110. 10.1186/s12985-018-1022-7", "ArticleIdList": ["10.1186/s12985-018-1022-7", "PMC6052623", "30021589"]}, {"Citation": "Paules, C. I., Marston, H. D., & Fauci, A. S. (2020). Coronavirus infections-more than just the common cold. JAMA, 323(8), 707\u2013708. 10.1001/jama.2020.0757", "ArticleIdList": ["10.1001/jama.2020.0757", "31971553"]}, {"Citation": "Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kal\u00e9, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781\u20131802. 10.1002/jcc.20289", "ArticleIdList": ["10.1002/jcc.20289", "PMC2486339", "16222654"]}, {"Citation": "Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015). PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43(W1), W443\u2013W447. 10.1093/nar/gkv315", "ArticleIdList": ["10.1093/nar/gkv315", "PMC4489249", "25873628"]}, {"Citation": "S\u00e1nchez-Linares, I., P\u00e9rez-S\u00e1nchez, H., Cecilia, J. M., & Garc\u00eda, J. M. (2012). High-Throughput parallel blind virtual screening using BINDSURF. BMC Bioinformatics, 13(Suppl 14), S13. 10.1186/1471-2105-13-S14-S13", "ArticleIdList": ["10.1186/1471-2105-13-S14-S13", "PMC3504923", "23095663"]}, {"Citation": "Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020). Structural basis of receptor recognition by SARS-CoV-2. Nature, 581(7807), 221\u2013224. 10.1038/s41586-020-2179-y", "ArticleIdList": ["10.1038/s41586-020-2179-y", "PMC7328981", "32225175"]}, {"Citation": "Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S., & Gallagher, T. (2011). A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of Virology, 85(2), 873\u2013882. 10.1128/JVI.02062-10", "ArticleIdList": ["10.1128/JVI.02062-10", "PMC3020023", "21068237"]}, {"Citation": "Simmons, G., Zmora, P., Gierer, S., Heurich, A., & P\u00f6hlmann, S. (2013). Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research. Antiviral Research, 100(3), 605\u2013614. 10.1016/j.antiviral.2013.09.028", "ArticleIdList": ["10.1016/j.antiviral.2013.09.028", "PMC3889862", "24121034"]}, {"Citation": "Song, W., Gui, M., Wang, X., & Xiang, Y. (2018). Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathogens, 14(8), e1007236. 10.1371/journal.ppat.1007236", "ArticleIdList": ["10.1371/journal.ppat.1007236", "PMC6107290", "30102747"]}, {"Citation": "Tong, T. R. (2009). Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections. Infectious Disorder Drug Targets, 9(2), 223\u2013245. 10.2174/187152609787847659", "ArticleIdList": ["10.2174/187152609787847659", "19275708"]}, {"Citation": "Towler, P., Staker, B., Prasad, S., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N., Patane, M., & Pantoliano, M. (2004). ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. The Journal of Biological Chemistry, 279(17), 17996\u201318007. 10.1074/jbc.M311191200", "ArticleIdList": ["10.1074/jbc.M311191200", "PMC7980034", "14754895"]}, {"Citation": "Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455\u2013461. 10.1002/jcc", "ArticleIdList": ["10.1002/jcc", "PMC3041641", "19499576"]}, {"Citation": "Tubiana, T., Carvaillo, J.-C., Boulard, Y., & Bressanelli, S. (2018). TTClust: A versatile molecular simulation trajectory clustering program with graphical summaries. Journal of Chemical Information and Modeling, 58(11), 2178\u20132182. 10.1021/acs.jcim.8b00512", "ArticleIdList": ["10.1021/acs.jcim.8b00512", "30351057"]}, {"Citation": "Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181(2), 281\u2013212. 10.1016/j.cell.2020.02.058", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Walsh, E. E., Shin, J. H., & Falsey, A. R. (2013). Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. The Journal of Infectious Diseases, 208(10), 1634\u20131642. 10.1093/infdis/jit393", "ArticleIdList": ["10.1093/infdis/jit393", "PMC3805243", "23922367"]}, {"Citation": "Wan, Y., Shang, J., Graham, R., Baric, R. S., Ralph, S., & Li, F. (2020). Receptor recognition by the Novel Coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology, 94(7), e00127. 10.1128/JVI.00127-20", "ArticleIdList": ["10.1128/JVI.00127-20", "PMC7081895", "31996437"]}, {"Citation": "WHO  (2020). Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19).\nhttps://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf"}, {"Citation": "Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, N.Y.), 367(6483), 1260\u20131263. 10.1126/science.aax0902", "ArticleIdList": ["10.1126/science.aax0902", "PMC7164637", "32075877"]}, {"Citation": "Wu, K., Peng, G., Wilken, M., Geraghty, R. J., & Li, F. (2012). Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus. The Journal of Biological Chemistry, 287(12), 8904\u20138911. 10.1074/jbc.M111.325803", "ArticleIdList": ["10.1074/jbc.M111.325803", "PMC3308800", "22291007"]}, {"Citation": "Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., Qin, C., Sun, F., Shi, Z., Zhu, Y., Jiang, S., & Lu, L. (2020). Inhibition of SARS-CoV-2 (previously 2019-nCoV)\u00a0infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion . Cell Research, 30(4), 343\u2013355. 10.1038/s41422-020-0305-x", "ArticleIdList": ["10.1038/s41422-020-0305-x", "PMC7104723", "32231345"]}, {"Citation": "Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China: Life Sciences, 63(3), 457\u2013460. 10.1007/s11427-020-1637-5", "ArticleIdList": ["10.1007/s11427-020-1637-5", "PMC7089049", "32009228"]}, {"Citation": "Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue, J. I., & Matsuda, Z. (2016). Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome Coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. Antimicrobial Agents and Chemotherapy, 60(11), 6532\u20136539. 10.1128/AAC.01043-16", "ArticleIdList": ["10.1128/AAC.01043-16", "PMC5075056", "27550352"]}, {"Citation": "Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (New York, N.Y.), 367(6485), 1444\u20131448. 10.1126/science.abb2762", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Yuan, Y., Cao, D., Zhang, Y., Ma, J., Qi, J., Wang, Q., Lu, G., Wu, Y., Yan, J., Shi, Y., Zhang, X., & Gao, G. F. (2017). Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nature Communications, 8(1), 1\u20139. 10.1038/ncomms15092", "ArticleIdList": ["10.1038/ncomms15092", "PMC5394239", "28393837"]}, {"Citation": "Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46(4), 586\u2013585. 10.1007/s00134-020-05985-9", "ArticleIdList": ["10.1007/s00134-020-05985-9", "PMC7079879", "32125455"]}, {"Citation": "Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020). Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv, 10.1101/2020.01.26.919985", "ArticleIdList": ["10.1101/2020.01.26.919985", "PMC7462411", "32663409"]}, {"Citation": "Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., \u2026 Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270\u2013274. 10.1038/s41586-020-2012-7", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Zhou, Y., Vedantham, P., Lu, K., Agudelo, J., Carrion, R., Nunneley, J. W., Barnard, D., P\u00f6hlmann, S., McKerrow, J. H., Renslo, A. R., & Simmons, G. (2015). Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Research, 116, 76\u201384. 10.1016/j.antiviral.2015.01.011", "ArticleIdList": ["10.1016/j.antiviral.2015.01.011", "PMC4774534", "25666761"]}]}], "History": [{"Year": "2020", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "22", "Hour": "8", "Minute": "40"}, {"Year": "2020", "Month": "10", "Day": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33089728", "PMC7594191", "10.1080/07391102.2020.1835726"]}}]}